- support
- info@evidentic.com
- +49 (0) 30 959 99 8831
Therapeutic Sacituzumab Govitecan ADC from the original Trodelvy® commercial drug.
Showing the single result
ProductBatch | Antigen | Molecular Class | Drug Brand | Product Concentration | CoA | Quantity per vial | Storage Temperature | Expiry Date | Price from | |
|---|---|---|---|---|---|---|---|---|---|---|
Trop-2-directed ADC |
Antibody-drug conjugate (ADC) |
Trodelvy® |
10 mg/mL |
– |
4 mg |
-80°C |
08/2025 |
299,00 € |
Evidentic GmbH
Martin-Buber-Str. 10
14163 Berlin
